| What is the impact of acute and chronic orofacial pain on quality of life? SS Shueb, DR Nixdorf, MT John, BF Alonso, J Durham Journal of dentistry 43 (10), 1203-1210, 2015 | 158 | 2015 |
| Examining the sensitivity and specificity of 2 screening instruments: odontogenic or temporomandibular disorder pain? BF Alonso, DR Nixdorf, SS Shueb, MT John, AS Law, J Durham Journal of Endodontics 43 (1), 36-45, 2017 | 21 | 2017 |
| Targeting MOR-mGluR5 heteromers reduces bone cancer pain by activating MOR and inhibiting mGluR5 SS Shueb, SJ Erb, MM Lunzer, R Speltz, C Harding-Rose, E Akgün, ... Neuropharmacology 160, 107690, 2019 | 18 | 2019 |
| PROSPERO International prospective register of systematic reviews WHO LIS | 14* | 2018 |
| Nonodontogenic “tooth pain” of nose and sinus origin SS Shueb, HC Boyer, DR Nixdorf J Am Dent Assoc 147 (6), 457-9, 2016 | 9 | 2016 |
| Initial accuracy assessment of the modified S-LANSS for the detection of neuropathic orofacial pain conditions. A Herrero Babiloni, DR Nixdorf, AS Law, EJ Moana-Filho, SS Shueb, ... Quintessence International 48 (5), 2017 | 8 | 2017 |
| The bivalent ligand, MMG22, reduces neuropathic pain after nerve injury without the side effects of traditional opioids R Speltz, MM Lunzer, SS Shueb, E Akgün, R Reed, A Kalyuzhny, ... Pain 161 (9), 2041-2057, 2020 | 5 | 2020 |
| Comparing the oral health related quality of life in four orofacial pain conditions S Shueb University of Minnesota, 2014 | 1 | 2014 |
| Bivalent Ligand MMG22 Reduces Bone Cancer Pain without Tolerance or Sedation SS Shueb University of Minnesota, 2022 | | 2022 |
